Contagion®
@contagionlive.bsky.social
740 followers 450 following 980 posts
Providing timely news to improve the diagnosis, treatment, and prevention of infectious diseases. Read our coverage: contagionlive.com
Posts Media Videos Starter Packs
Pinned
contagionlive.bsky.social
Our Summer issue is here! Read about treatments on stenotrophomonas maltophilia, clinical care for people with HIV who are aging, and how biosurveillance is a significant tool in infectious disease. #IDsky #Medsky

Read the issue here: indd.adobe.com/view/071dfa6...
contagionlive.bsky.social
Barry Kreiswirth, PhD, discusses this emerging challenge that is ongoing in both the community and healthcare settings, especially around resistant urinary tract infections and how this type of resistance can grow exponentially across strain and pathogens. #IDsky
Uncovering the Challenges of Multidrug-Resistant Klebsiella Infections | Contagion Live
The Center for Discovery and Innovation’s Barry Kreiswirth, PhD, discusses this emerging challenge that is ongoing in both the community and healthcare settings, especially around resistant urinary tr...
www.contagionlive.com
contagionlive.bsky.social
David Perlin, PhD, chief scientific officer and executive vice president, the Center for Discovery and Innovation (CDI), talks about his team’s work around developing a diagnostic for Candida auris, and what they are working on in terms of developing antifungals. #IDsky #Medsky
The Center for Discovery and Innovation’s Commitment to Fungal Diagnostics and Treatment
David Perlin, PhD, chief scientific officer and executive vice president, the Center for Discovery and Innovation (CDI), talks about his team’s work around developing a diagnostic for Candida auris, a...
www.contagionlive.com
contagionlive.bsky.social
In our continuing Media Day series, the Center for Discovery and Innovation’s Chief Scientific Officer David Perlin, PhD, discusses the factors for the growing number of cases, and the difficulties in developing such treatments. #IDsky #Medsky
A Limited Antifungal Market is Treating an Increasing Number of Fungal Infections
The Center for Discovery and Innovation’s Chief Scientific Officer David Perlin, PhD, discusses the factors for the growing number of cases, and the difficulties in developing such treatments.
www.contagionlive.com
contagionlive.bsky.social
The act aims to expand testing, treatment, and prevention through a subscription-based model. The legislation would invest billions in public health infrastructure, remove barriers to curative therapies, and ensure high-risk and underserved populations have access to life-saving HCV treatment.
Cure Hepatitis C Act 2025: US Strategy to End Hepatitis C
Through the bipartisan Cure Hepatitis C Act of 2025, legislation seeks to provide nationwide hepatitis C treatment and strengthen public health infrastructure by expanding testing, treatment, and prev...
www.contagionlive.com
contagionlive.bsky.social
Your liver silently powers and protects your body every day, but untreated hepatitis infections, excessive alcohol, and poor diet can destroy its vital cells, leading to fatigue, cirrhosis, and liver cancer if not prevented through awareness and care.
Hepatitis and Cancer: Silent Threats to the Liver
Your liver silently powers and protects your body every day, but untreated hepatitis infections, excessive alcohol, and poor diet can destroy its vital cells, leading to fatigue, cirrhosis, and liver ...
www.contagionlive.com
contagionlive.bsky.social
George Sakoulas, MD, discusses how antimicrobial selection for patients with pneumonia depends on illness severity, seasonal pathogen patterns, comorbidities, and prior antibiotic exposure, with particular attention to high-risk populations requiring tailored therapy.
Tailoring Pneumonia Treatment: How Severity, Season, and Comorbidities Guide Antimicrobial Choices
An expert discusses how antimicrobial selection for patients with pneumonia depends on illness severity, seasonal pathogen patterns, comorbidities, and prior antibiotic exposure, with particular atten...
www.contagionlive.com
contagionlive.bsky.social
S aureus bloodstream infections, particularly those caused by MRSA, remain a major cause of morbidity and mortality, underscoring the need for novel, broad-spectrum treatments like ceftobiprole that can address both resistant and susceptible strains. #IDsky #Medsky
Staphylococcus aureus Bloodstream Infections: Persistent Challenges and Emerging Therapeutic Opportunities
Despite modest progress, Staphylococcus aureus bloodstream infections—particularly those caused by MRSA—remain a major cause of morbidity and mortality, underscoring the urgent need for novel, broad-s...
www.contagionlive.com
contagionlive.bsky.social
University of Oregon researchers found that adding a common chemical, chlorate, to standard antibiotics made them up to 10,000 times more effective in lab tests against hard-to-treat bacteria, offering a potential breakthrough for chronic wound care.
Chemical Compound Supercharges Antibiotics to Fight Chronic Wound Infections
University of Oregon researchers found that adding a common chemical, chlorate, to standard antibiotics made them up to 10,000 times more effective in lab tests against hard-to-treat bacteria, offerin...
www.contagionlive.com
contagionlive.bsky.social
Today is #WorldMRSADay! In a previous interview, Jeanine Thomas, president and founder of MRSA Survivors Network, talks about her personal with it, her work as an advocate, and the need for data and awareness to bring it to the forefront again.
Bringing MRSA Back to the Forefront
Jeanine Thomas, president and founder of MRSA Survivors Network, talks about her personal battle with osteomyelitis, her work as an advocate, and the need for data and awareness to bring it to the for...
www.contagionlive.com